Medical device supply chain managers will likely conclude that 2020 is a year best forgotten. After an early continuation of 2019’s strong sales, the arrival of COVID-19 crippled order books throughout the spring and summer. While few companies lost OEM customers, almost all organizations experienced supply delays or backlogs. At the start of the fall, orders began trickling in again but the damage is done. 2020 will see most supply chain players with revenues 10 percent to 20 percent below last year’s levels. Despite lower profits, however, long-term gains will return for medtech firms willing to learn from the pandemic-induced demand shock. The following four measures will benefit most any company. Survive by Managing Cash and Inventory Click Here For Complete Article Text
|
||||||||||||||||||
| Application Sequencing | ||||||||||||||||||
|
||||||||||||||||||
| Company | Product | Process | Other Subjects | Event | Event Date | Location | Publication | Publication Date | Text Descriptor | |||||||||
|
|
|
|
|
|
|
|
|||||||||||